http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010115277-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-21 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 |
| filingDate | 2008-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010115277-A |
| titleOfInvention | HIGH-CALOR NUTRIENT COMPOSITIONS |
| abstract | 1. The use of a composition containing protein, fat, digestible and non-digestible carbohydrates and nucleotides in the production of high-calorie compositions for the treatment and / or prevention of stunting in infants, characterized in that! but. has an energy density of at least 0.9 kcal / ml and preferably below 2.0 kcal / ml; ! b. contains a protein component in an amount providing at least 9.5% of the total calories; and! from. contains at least 0.1 wt.% long chain polyunsaturated fatty acids of the total amount of fatty acids; and! d. contains at least 0.1 wt.% indigestible carbohydrates based on the dry weight of the composition; and! e. contains at least 1 ยท 10-4 wt.% nucleotides of the dry weight of the composition. ! 2. The use according to claim 1, characterized in that the composition is administered through a probe. ! 3. The use according to claim 1, characterized in that said infant has intolerance to the gastrointestinal tract, cystic fibrosis, dysfunction of the heart, trauma, cancer and / or paralysis, or which has undergone or will undergo surgery. ! 4. The use according to claim 2, characterized in that said infant has intolerance to the gastrointestinal tract, cystic fibrosis, dysfunction of the heart, trauma, cancer and / or paralysis, or which has undergone or will undergo surgery. ! 5. The use according to any one of claims 1 to 4, characterized in that said non-digestible carbohydrate is selected from the group consisting of fructooligosaccharides, galactooligosaccharides, sialooligosaccharides, xylooligosaccharides, inulin, gum arabic, guar gum, resistant starch, |
| priorityDate | 2007-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.